By Elizabeth Lincoln, M.A., global director of engagement, DIA
Patient-centricity is rapidly becoming the central theme of next-generation healthcare product development. Beginning in late 2015, DIA, in collaboration with the Tufts University Center for the Study of Drug Development (CSDD), initiated research we titled the Study of Patient-Centric Initiatives in Drug Development. The goal of this ongoing research is to quantify the benefit of engaging patients in all stages of healthcare product development. This article will share initial insights we have gleaned from our patient-centricity study.